Description
Retinalamin® is a complex peptide preparation manufactured by Geropharm (St. Petersburg, Russia) through standardized enzymatic extraction of bovine retinal tissue, yielding a defined mixture of low-molecular-weight peptides and amino acid fragments in the approximate 1,000 – 10,000 Da molecular weight range. The preparation was developed within the broader Russian complex peptide preparation research tradition — the same scientific framework that produced Cortexin (cerebral cortex peptides) and Thymalin (thymus peptides). Retinalamin has been investigated in Russian academic and clinical research literature over multiple decades for retinal cell biology research, comparative complex peptide preparation pharmacology, and comparative research versus other Geropharm-manufactured tissue-derived peptide preparations. The compound is offered here as a complex polypeptide preparation for laboratory research applications, supplied as a 10 vial × 5mg presentation in the original Geropharm manufacturer packaging. The compound has undergone clinical research investigation in Russia and CIS countries, though it remains an investigational research compound in US and Canadian markets without approved regulatory status.
Benefits (Research Focus)
• Complex retinal peptide research — studied as a complex peptide preparation derived from bovine retinal tissue for research applications
• Comparative Geropharm preparation research — investigated alongside Cortexin (cerebral cortex peptides) and Thymalin (thymus peptides) for comparative complex peptide preparation research within the Geropharm catalog
• Retinal cell biology research — explored for retinal cell biology research endpoints in cell culture research models
• Tissue-specific peptide preparation research — examined for peptide profile characterization from retinal tissue versus other tissue sources
• Comparative complex peptide research — researched alongside other complex peptide preparations for comparative pharmacology studies
What Researchers Look At
• Peptide profile analysis and molecular weight distribution characterization of the retinal peptide preparation
• Comparative pharmacology versus Cortexin (cerebral cortex preparation) and Thymalin (thymus preparation)
• Retinal cell viability and morphology endpoints in cell research models
• Batch-to-batch composition consistency and standardization research
• Comparative complex peptide preparation research across tissue-specific extraction sources
Quick Specs
• Form: Lyophilized peptide complex (white to off-white powder)
• Net Peptide Content: 5 mg per vial
• Quantity: 10 vials per package (50 mg total)
• Manufacturing: Geropharm (St. Petersburg, Russia)
• Reconstitution: Bacteriostatic or sterile water (added by the end researcher)
• Composition: Mixed low-molecular-weight peptides and amino acids extracted from bovine retinal tissue (peptide complex, not single-sequence)
• Identity: Peptide profile per manufacturer documentation
• Storage: Protect from light
Identity Basics
• Product: Retinalamin (bovine retinal peptide preparation)
• Synonyms: Retinalamin complex; bovine retinal peptide hydrolysate; retinal polypeptide preparation; Ретиналамин (Russian designation)
• Class: Complex peptide preparation; not a single-sequence peptide; tissue-derived polypeptide extract
• Source: Enzymatic extraction of bovine retinal tissue under standardized Geropharm manufacturing process
• Composition: Mixed low-molecular-weight peptides and amino acid fragments (approximately 1,000 – 10,000 Da molecular weight range)
• Manufacturer: Geropharm (St. Petersburg, Russia)
• Package format: 10 vials × 5 mg per vial (50 mg total per package)
⚠️ Disclaimer
- This product is intended for laboratory research use only.
- Not for human or veterinary use.
- Not approved for diagnostic, therapeutic, or medical applications by FDA or Health Canada.
- Handle using appropriate laboratory safety procedures and personal protective equipment.
- Not for pediatric research applications outside controlled laboratory settings.
Manufacturer Verification Notice: This product is supplied in its original Geropharm-manufactured packaging with manufacturer-issued batch number and expiration date. Verification of authenticity relies on Geropharm manufacturer documentation rather than third-party laboratory analysis (which is the standard for synthetic research peptides). Customers should verify package integrity, intact original packaging, and visible batch/expiration markings upon receipt.
Manufacturer Documentation
• Manufacturer: Geropharm (St. Petersburg, Russia)
• Verification: Each package includes Geropharm-issued batch number and expiration date for manufacturer traceability
• Related Geropharm complex peptide preparations: Cortexin (cerebral cortex peptide preparation), Thymalin (thymus peptide preparation)
• Third-Party Testing Note: Independent third-party HPLC purity testing (such as Janoshik analysis) applies to single-sequence synthetic research peptides. Retinalamin is a complex peptide preparation supplied in its original manufacturer packaging and is verified by Geropharm batch documentation rather than third-party single-peptide analysis.
